Short-Term Corticosteroids in SARS-CoV2 Patients: Hospitalists’ Perspective

Vijairam Selvaraj, Kwame Dapaah-Afriyie, Arkadiy Finn, Timothy Flanigan
doi: https://doi.org/10.1101/2020.06.19.20109173

Article Information

doi 
https://doi.org/10.1101/2020.06.19.20109173
History 
  • June 27, 2020.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Vijairam Selvaraj, M.D.1,2,*,
  2. Kwame Dapaah-Afriyie, M.D.1,2,
  3. Arkadiy Finn, M.D.1,2 and
  4. Timothy Flanigan, M.D.2,3
  1. 1Division of Hospital Medicine, The Miriam Hospital, 164 Summit Avenue, Providence, RI. 02906
  2. 2Warren Alpert Medical School of Brown University, 222 Richmond St, Providence, RI, 02903
  3. 3Department of Infectious Diseases, Brown Medicine, 164 Summit Avenue, Providence, RI, 02906
  1. ↵*Corresponding Author Vijairam Selvaraj, MD, MPH, Miriam Hospital, 164 Summit Ave, Providence, RI 02906, Email: vijairam.selvaraj{at}lifespan.org, Phone: 413-271-0421
Back to top
Posted June 27, 2020.
Download PDF
Data/Code
Email
Short-Term Corticosteroids in SARS-CoV2 Patients: Hospitalists’ Perspective
Vijairam Selvaraj, Kwame Dapaah-Afriyie, Arkadiy Finn, Timothy Flanigan
medRxiv 2020.06.19.20109173; doi: https://doi.org/10.1101/2020.06.19.20109173
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area